🔧На сайте запланированы технические работы
25.12.2025 в промежутке с 18:00 до 21:00 по Московскому времени (GMT+3) на сайте будут проводиться плановые технические работы. Возможны перебои с доступом к сайту. Приносим извинения за временные неудобства. Благодарим за понимание!
🔧Site maintenance is scheduled.
Scheduled maintenance will be performed on the site from 6:00 PM to 9:00 PM Moscow time (GMT+3) on December 25, 2025. Site access may be interrupted. We apologize for the inconvenience. Thank you for your understanding!

 

Cellular Mechanisms of Aortic Valve Calcification


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Comparative in vitro study examined the osteogenic potential of interstitial cells of aortic valve obtained from the patients with aortic stenosis and from control recipients of orthotopic heart transplantation with intact aortic valve. The osteogenic inductors augmented mineralization of aortic valve interstitial cells (AVIC) in patients with aortic stenosis in comparison with the control level. Native AVIC culture of aortic stenosis patients demonstrated overexpression of osteopontin gene (OPN) and underexpression of osteoprotegerin gene (OPG) in comparison with control levels. In both groups, AVIC differentiation was associated with overexpression of RUNX2 and SPRY1 genes. In AVIC of aortic stenosis patients, expression of BMP2 gene was significantly greater than the control level. The study revealed an enhanced sensitivity of AVIC to osteogenic inductors in aortic stenosis patients, which indicates probable implication of OPN, OPG, and BMP2 genes in pathogenesis of aortic valve calcification.

About the authors

E. V. Zhiduleva

V. A. Almazov National Medical Research Center

Author for correspondence.
Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

O. B. Irtyuga

V. A. Almazov National Medical Research Center

Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

A. A. Shishkova

V. A. Almazov National Medical Research Center

Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

E. V. Ignat’eva

V. A. Almazov National Medical Research Center

Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

A. S. Kostina

V. A. Almazov National Medical Research Center

Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

K. A. Levchuk

V. A. Almazov National Medical Research Center

Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

A. S. Golovkin

V. A. Almazov National Medical Research Center

Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

A. Yu. Rylov

V. A. Almazov National Medical Research Center

Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

A. A. Kostareva

V. A. Almazov National Medical Research Center

Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

O. M. Moiseeva

V. A. Almazov National Medical Research Center

Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

A. B. Malashicheva

V. A. Almazov National Medical Research Center

Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

M. L. Gordeev

V. A. Almazov National Medical Research Center

Email: zhiduleva_ev@almazovcentre.ru
Russian Federation, St. Petersburg

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature